Evidence on the optimal anticoagulation regimen for hemodialysis in patients at high bleeding risk is scarce. The HepZero study is the first large multinational study comparing two different anticoagulation strategies to avoid systemic heparinization. The use of a heparin-coated dialysis membrane proved to be non-inferior to saline infusion. Superiority of either treatment, however, could not be demonstrated. These findings challenge current guidelines but equally raise questions on the choice of either strategy as compared with regional citrate anticoagulation.status: publishe
Numerous acquired hemostatic abnormalities have been identified in renal insufficiency. Hemodial-ysi...
Background: Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting ...
In patients with enhanced risk for bleeding, heparin-free hemodialysis (HD) with conventional dialyz...
Evidence on the optimal anticoagulation regimen for hemodialysis in patients at high bleeding risk i...
International audienceBACKGROUND: Anticoagulation for chronic dialysis patients with contraindicatio...
International audienceHeparin is used to prevent clotting during hemodialysis, but heparin-free hemo...
Heparin is used to prevent clotting during hemodialysis, but heparin-free hemodialysis is sometimes ...
In this clinical trial, we aimed to compare three means of performing chronic hemodialysis in patien...
Anticoagulation is a prerequisite for successful haemodialysis. Heparin and low-molecular weight hep...
Background. Binding of polycationic unfractionated heparin onto the modified AN69 polyacrylonitrile ...
Objective: In this clinical trial, we aimed to compare three means of performing chronic hemodialysi...
Hemodialysis is the most widely applied renal replacement therapy. Due to the fact that the hemocyte...
Introduction: Hemodialysis treatment requires anticoagulation to prevent thrombosis of the dialyzer....
Heparin free dialysis: comparative data and results in high risk patients. Heparin free hemodialysis...
Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. St...
Numerous acquired hemostatic abnormalities have been identified in renal insufficiency. Hemodial-ysi...
Background: Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting ...
In patients with enhanced risk for bleeding, heparin-free hemodialysis (HD) with conventional dialyz...
Evidence on the optimal anticoagulation regimen for hemodialysis in patients at high bleeding risk i...
International audienceBACKGROUND: Anticoagulation for chronic dialysis patients with contraindicatio...
International audienceHeparin is used to prevent clotting during hemodialysis, but heparin-free hemo...
Heparin is used to prevent clotting during hemodialysis, but heparin-free hemodialysis is sometimes ...
In this clinical trial, we aimed to compare three means of performing chronic hemodialysis in patien...
Anticoagulation is a prerequisite for successful haemodialysis. Heparin and low-molecular weight hep...
Background. Binding of polycationic unfractionated heparin onto the modified AN69 polyacrylonitrile ...
Objective: In this clinical trial, we aimed to compare three means of performing chronic hemodialysi...
Hemodialysis is the most widely applied renal replacement therapy. Due to the fact that the hemocyte...
Introduction: Hemodialysis treatment requires anticoagulation to prevent thrombosis of the dialyzer....
Heparin free dialysis: comparative data and results in high risk patients. Heparin free hemodialysis...
Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. St...
Numerous acquired hemostatic abnormalities have been identified in renal insufficiency. Hemodial-ysi...
Background: Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting ...
In patients with enhanced risk for bleeding, heparin-free hemodialysis (HD) with conventional dialyz...